Paul W. Eldridge

1.9k total citations
23 papers, 1.1k citations indexed

About

Paul W. Eldridge is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Paul W. Eldridge has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Hematology and 11 papers in Immunology. Recurrent topics in Paul W. Eldridge's work include Hematopoietic Stem Cell Transplantation (12 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (8 papers). Paul W. Eldridge is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (8 papers). Paul W. Eldridge collaborates with scholars based in United States, Saudi Arabia and Singapore. Paul W. Eldridge's co-authors include Wing Leung, Timothy Lockey, Hiroyuki Fujisaki, Dario Campana, Noriko Shimasaki, Harumi Kakuda, Chihaya Imai, Jing Ma, Gary Van Zant and Michael J. Dewey and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Paul W. Eldridge

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul W. Eldridge United States	14	750	627	361	235	173	23	1.1k
Felix S. Lichtenegger Germany	18	698 0.9×	684 1.1×	440 1.2×	428 1.8×	109 0.6×	35	1.3k
Nicoletta Cieri Italy	13	708 0.9×	786 1.3×	363 1.0×	295 1.3×	237 1.4×	31	1.3k
Fengshuo Lan United States	12	866 1.2×	518 0.8×	441 1.2×	123 0.5×	161 0.9×	14	1.1k
Susan K. Fautsch United States	8	1.5k 2.0×	1.0k 1.6×	624 1.7×	130 0.6×	100 0.6×	9	1.7k
Jan Spanholtz Netherlands	23	1.2k 1.6×	922 1.5×	317 0.9×	281 1.2×	109 0.6×	40	1.5k
Susann Szmania United States	17	994 1.3×	850 1.4×	590 1.6×	394 1.7×	81 0.5×	40	1.5k
Bartosz Grzywacz United States	14	960 1.3×	597 1.0×	266 0.7×	204 0.9×	38 0.2×	31	1.2k
Christopher S. Seet United States	14	407 0.5×	371 0.6×	186 0.5×	438 1.9×	72 0.4×	35	899
Srinivas S. Somanchi United States	15	1.1k 1.5×	880 1.4×	195 0.5×	224 1.0×	102 0.6×	30	1.3k
Harumi Kakuda Japan	12	586 0.8×	474 0.8×	398 1.1×	211 0.9×	58 0.3×	28	947

Countries citing papers authored by Paul W. Eldridge

Since Specialization

Citations

This map shows the geographic impact of Paul W. Eldridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Eldridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Eldridge more than expected).

Fields of papers citing papers by Paul W. Eldridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul W. Eldridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Eldridge. The network helps show where Paul W. Eldridge may publish in the future.

Co-authorship network of co-authors of Paul W. Eldridge

This figure shows the co-authorship network connecting the top 25 collaborators of Paul W. Eldridge. A scholar is included among the top collaborators of Paul W. Eldridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul W. Eldridge. Paul W. Eldridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Worel, Nina, Bronwen E. Shaw, Mahmoud Aljurf, et al.. (2020). Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. Transplantation and Cellular Therapy. 27(3). 270.e1–270.e6. 13 indexed citations

Harif, Mhamed, Daniel Weisdorf, Nicolás Novitzky, et al.. (2019). Special report. Hematology/Oncology and Stem Cell Therapy. 13(4). 202–207. 16 indexed citations

Park, Steven I., Jonathan S. Serody, Thomas C. Shea, et al.. (2017). A phase 1b/2 study of CD30-specific chimeric antigen receptor T-cell (CAR-T) therapy in combination with bendamustine in patients with CD30+ Hodgkin and non-Hodgkin lymphoma.. Journal of Clinical Oncology. 35(15_suppl). TPS3095–TPS3095. 8 indexed citations

Keever-Taylor, Carolyn A., Ineke Slaper‐Cortenbach, Christina M. Celluzzi, et al.. (2015). Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation. Cytotherapy. 17(12). 1831–1844. 4 indexed citations

Triplett, Brandon M., David Shook, Paul W. Eldridge, et al.. (2015). Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies. Bone Marrow Transplantation. 50(7). 968–977. 71 indexed citations

Shook, David, Brandon M. Triplett, Paul W. Eldridge, et al.. (2015). Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability. Pediatric Blood & Cancer. 62(4). 666–673. 40 indexed citations

Chan, Ying N., Robert E. Throm, Yi Li, et al.. (2014). Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity. Leukemia. 29(2). 387–395. 41 indexed citations

Wright, Stephen E., et al.. (2014). TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells. Oncology Letters. 7(6). 2113–2117. 5 indexed citations

Rujkijyanont, Piya, Wing Keung Chan, Paul W. Eldridge, et al.. (2013). Ex Vivo Activation of CD56+ Immune Cells That Eradicate Neuroblastoma. Cancer Research. 73(8). 2608–2618. 20 indexed citations

10.

Shimasaki, Noriko, Hiroyuki Fujisaki, Duck Cho, et al.. (2012). A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies. Cytotherapy. 14(7). 830–840. 141 indexed citations

11.

Greene, Michael R., Timothy Lockey, Perdeep K. Mehta, et al.. (2012). Transduction of Human CD34 ⁺ Repopulating Cells with a Self-Inactivating Lentiviral Vector for SCID-X1 Produced at Clinical Scale by a Stable Cell Line. Human Gene Therapy Methods. 23(5). 297–308. 40 indexed citations

12.

Rujkijyanont, Piya, Kwan Gan, Jie Yang, et al.. (2012). Prediction of CD34 + cell yield in hematopoietic cell products from children by peripheral blood CD34 + cell counts. Cytotherapy. 14(4). 473–482. 14 indexed citations

13.

Fujisaki, Hiroyuki, Harumi Kakuda, Noriko Shimasaki, et al.. (2009). Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy. Cancer Research. 69(9). 4010–4017. 471 indexed citations

14.

Kasow, Kimberly A., et al.. (2007). CD34+ Hematopoietic Progenitor Cell Selection of Bone Marrow Grafts for Autologous Transplantation in Pediatric Patients. Biology of Blood and Marrow Transplantation. 13(5). 608–614. 11 indexed citations

15.

Wichlan, David, Philippa L. Roddam, Paul W. Eldridge, Rupert Handgretinger, & Janice M. Riberdy. (2006). Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity. Journal of Immunological Methods. 315(1-2). 27–36. 25 indexed citations

16.

Barfield, Raymond, et al.. (2005). Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia. Pediatric Blood & Cancer. 48(3). 349–353. 14 indexed citations

17.

Hale, Gregory A., Edwin M. Horwitz, Wing Leung, et al.. (2004). CD133+ Hematopoietic Cells Successfully Reconstitute Hematopoiesis Following Autologous Peripheral Blood Stem Cell Transplantation.. Blood. 104(11). 444–444. 2 indexed citations

18.

Wright, Stephen E., Kathleen Rewers‐Felkins, Paul W. Eldridge, et al.. (2002). Adoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cells. International Journal of Molecular Medicine. 9(4). 401–4. 13 indexed citations

19.

Zant, Gary Van, et al.. (1990). Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice.. The Journal of Experimental Medicine. 171(5). 1547–1565. 85 indexed citations

20.

Dewey, Michael J. & Paul W. Eldridge. (1982). Friend viral pathogenesis in c57bl/6-dba/2 allophenic mice.. The Mouseion at the JAXlibrary (Jackson Laboratory). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact